C
한미사이언스
008930KOSPI54.0 / 100
Reference Date: 2026-10-23
Financial Score20.5 / 40
News Sentiment12.5 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 16.5% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Hanmi Science operates as a business holding company, generating revenue through equity income from subsidiaries, patent and trademark licensing fees, and healthcare and pharmaceutical wholesale businesses. The company focuses on innovation across medical devices, food, beauty care, and IT solutions, and expanded its portfolio through the 2022 acquisition of Hanmi Healthcare.
Number of Employees
489people
Average Salary
72.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
24.61Industry Average 15.001.5Point
1.6x industry avg (risky)
PBR
3.02Industry Average 1.200.0Point
2.5x industry avg (risky)
ROE
13.09Industry Average 8.005.5Point
1.6x industry avg (good)
Debt Ratio
4.83Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20255.5 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲4.3% (2-year basis)
Operating Profit Growth Rate
2.0 / 3
Avg ▲9.9% (2-year basis)
ROE Trend
2.5 / 4
Avg ROE 11.8% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position5.0Point
52w mid range (40%)
Current 42,350Won52-week high 66,20052-week low 26,100
1-month return0.0Point
1m -16.47% (strong drop)
Volume trend6.0Point
Volume surge
Detailed Disclosure
11 totalPositive 0Neutral 11Negative 0
- Neutral주식등의대량보유상황보고서(일반)2026-10-16
- Neutral결산실적공시예고(안내공시)2026-10-16
- Neutral기업설명회(IR)개최(안내공시)2026-10-16
- Neutral최대주주등소유주식변동신고서2026-10-15
- Neutral주식등의대량보유상황보고서(일반)2026-10-07